On October 23, 2024, BioVie Inc., a clinical-stage company focused on developing treatments for chronic debilitating conditions, announced a registered direct offering and concurrent private placement. The offering involves the sale of 2,667,000 shares of Class A common stock at $2.25 per share, with gross proceeds expected to be approximately $6 million before fees and expenses. Concurrently, unregistered warrants to purchase an equivalent number of shares at $2.12 per share will be issued in a private placement. These warrants will be exercisable six months after issuance and will expire after five years. Additionally, a warrant was issued to the placement agent, ThinkEquity LLC, to purchase 133,350 shares at $2.8125 per share. The offering is anticipated to close on October 24, 2024, with the company intending to use the net...Show More

On October 23, 2024, BioVie Inc., a clinical-stage company focused on developing treatments for chronic debilitating conditions, announced a registered direct offering and concurrent private placement. The offering involves the sale of 2,667,000 shares of Class A common stock at $2.25 per share, with gross proceeds expected to be approximately $6 million before fees and expenses. Concurrently, unregistered warrants to purchase an equivalent number of shares at $2.12 per share will be issued in a private placement. These warrants will be exercisable six months after issuance and will expire after five years. Additionally, a warrant was issued to the placement agent, ThinkEquity LLC, to purchase 133,350 shares at $2.8125 per share. The offering is anticipated to close on October 24, 2024, with the company intending to use the net proceeds for working capital and general corporate purposes. The shares and warrants were offered under a shelf registration statement on Form S-3, previously filed and declared effective by the SEC. BioVie is required to file a registration statement for the resale of the Warrant Shares within 30 days post-closing of the Private Placement. The company also issued a press release on the same day to announce the offering.